Cargando…

Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma

BACKGROUND: Squamous cell carcinoma (SqCC) is a subtype of non-small cell lung cancer for which patient prognosis remains poor. The extracellular matrix (ECM) is critical in regulating cell behavior; however, its importance in tumor aggressiveness remains to be comprehensively characterized. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Amelia L., Bowman, Elise, Zingone, Adriana, Ryan, Brid M., Cooper, Wendy A., Kohonen-Corish, Maija, Harris, Curtis C., Cox, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677915/
https://www.ncbi.nlm.nih.gov/pubmed/36404344
http://dx.doi.org/10.1186/s13073-022-01127-6
_version_ 1784833894454919168
author Parker, Amelia L.
Bowman, Elise
Zingone, Adriana
Ryan, Brid M.
Cooper, Wendy A.
Kohonen-Corish, Maija
Harris, Curtis C.
Cox, Thomas R.
author_facet Parker, Amelia L.
Bowman, Elise
Zingone, Adriana
Ryan, Brid M.
Cooper, Wendy A.
Kohonen-Corish, Maija
Harris, Curtis C.
Cox, Thomas R.
author_sort Parker, Amelia L.
collection PubMed
description BACKGROUND: Squamous cell carcinoma (SqCC) is a subtype of non-small cell lung cancer for which patient prognosis remains poor. The extracellular matrix (ECM) is critical in regulating cell behavior; however, its importance in tumor aggressiveness remains to be comprehensively characterized. METHODS: Multi-omics data of SqCC human tumor specimens was combined to characterize ECM features associated with initiation and recurrence. Penalized logistic regression was used to define a matrix risk signature for SqCC tumors and its performance across a panel of tumor types and in SqCC premalignant lesions was evaluated. Consensus clustering was used to define prognostic matreotypes for SqCC tumors. Matreotype-specific tumor biology was defined by integration of bulk RNAseq with scRNAseq data, cell type deconvolution, analysis of ligand-receptor interactions and enriched biological pathways, and through cross comparison of matreotype expression profiles with aging and idiopathic pulmonary fibrosis lung profiles. RESULTS: This analysis revealed subtype-specific ECM signatures associated with tumor initiation that were predictive of premalignant progression. We identified an ECM-enriched tumor subtype associated with the poorest prognosis. In silico analysis indicates that matrix remodeling programs differentially activate intracellular signaling in tumor and stromal cells to reinforce matrix remodeling associated with resistance and progression. The matrix subtype with the poorest prognosis resembles ECM remodeling in idiopathic pulmonary fibrosis and may represent a field of cancerization associated with elevated cancer risk. CONCLUSIONS: Collectively, this analysis defines matrix-driven features of poor prognosis to inform precision medicine prevention and treatment strategies towards improving SqCC patient outcome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-022-01127-6.
format Online
Article
Text
id pubmed-9677915
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96779152022-11-22 Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma Parker, Amelia L. Bowman, Elise Zingone, Adriana Ryan, Brid M. Cooper, Wendy A. Kohonen-Corish, Maija Harris, Curtis C. Cox, Thomas R. Genome Med Research BACKGROUND: Squamous cell carcinoma (SqCC) is a subtype of non-small cell lung cancer for which patient prognosis remains poor. The extracellular matrix (ECM) is critical in regulating cell behavior; however, its importance in tumor aggressiveness remains to be comprehensively characterized. METHODS: Multi-omics data of SqCC human tumor specimens was combined to characterize ECM features associated with initiation and recurrence. Penalized logistic regression was used to define a matrix risk signature for SqCC tumors and its performance across a panel of tumor types and in SqCC premalignant lesions was evaluated. Consensus clustering was used to define prognostic matreotypes for SqCC tumors. Matreotype-specific tumor biology was defined by integration of bulk RNAseq with scRNAseq data, cell type deconvolution, analysis of ligand-receptor interactions and enriched biological pathways, and through cross comparison of matreotype expression profiles with aging and idiopathic pulmonary fibrosis lung profiles. RESULTS: This analysis revealed subtype-specific ECM signatures associated with tumor initiation that were predictive of premalignant progression. We identified an ECM-enriched tumor subtype associated with the poorest prognosis. In silico analysis indicates that matrix remodeling programs differentially activate intracellular signaling in tumor and stromal cells to reinforce matrix remodeling associated with resistance and progression. The matrix subtype with the poorest prognosis resembles ECM remodeling in idiopathic pulmonary fibrosis and may represent a field of cancerization associated with elevated cancer risk. CONCLUSIONS: Collectively, this analysis defines matrix-driven features of poor prognosis to inform precision medicine prevention and treatment strategies towards improving SqCC patient outcome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-022-01127-6. BioMed Central 2022-11-21 /pmc/articles/PMC9677915/ /pubmed/36404344 http://dx.doi.org/10.1186/s13073-022-01127-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Parker, Amelia L.
Bowman, Elise
Zingone, Adriana
Ryan, Brid M.
Cooper, Wendy A.
Kohonen-Corish, Maija
Harris, Curtis C.
Cox, Thomas R.
Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
title Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
title_full Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
title_fullStr Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
title_full_unstemmed Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
title_short Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
title_sort extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677915/
https://www.ncbi.nlm.nih.gov/pubmed/36404344
http://dx.doi.org/10.1186/s13073-022-01127-6
work_keys_str_mv AT parkeramelial extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT bowmanelise extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT zingoneadriana extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT ryanbridm extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT cooperwendya extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT kohonencorishmaija extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT harriscurtisc extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma
AT coxthomasr extracellularmatrixprofilesdetermineriskandprognosisofthesquamouscellcarcinomasubtypeofnonsmallcelllungcarcinoma